Vonafexor accepted as the generic name for EYP001 by the WHO

Published on 19/11/2020

We are pleased to announce that the World Health Organization (WHO) has accepted the international non-proprietary name (INN, or generic name) vonafexor for our FXR agonist lead candidate previously referred to as EYP001.

Read next in 'Latest news'

• ENYO Pharma featured in Biomim'BOOK 2021
• Etienne Morel's talk at the Virology Virtual Conference
• New publication : Mitochondrial morphodynamics alteration induced by influenza virus infection as a new antiviral strategy
• ENYO Pharma selected to take part in the French Tech 120 FT120 program
• New publication : A new class of molecule targeting the NEET family of proteins